EP4698283A1 - Probiotika enthaltende zusammensetzung zur telomeraseherstellung - Google Patents

Probiotika enthaltende zusammensetzung zur telomeraseherstellung

Info

Publication number
EP4698283A1
EP4698283A1 EP24726093.8A EP24726093A EP4698283A1 EP 4698283 A1 EP4698283 A1 EP 4698283A1 EP 24726093 A EP24726093 A EP 24726093A EP 4698283 A1 EP4698283 A1 EP 4698283A1
Authority
EP
European Patent Office
Prior art keywords
lactobacillus
formerly
composition
telomerase
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24726093.8A
Other languages
English (en)
French (fr)
Inventor
Jason Ryan STEINBRUNN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telomerase Company LLC
Original Assignee
Telomerase Company LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/612,750 external-priority patent/US20240352470A1/en
Application filed by Telomerase Company LLC filed Critical Telomerase Company LLC
Publication of EP4698283A1 publication Critical patent/EP4698283A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
EP24726093.8A 2023-04-20 2024-04-19 Probiotika enthaltende zusammensetzung zur telomeraseherstellung Pending EP4698283A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363497424P 2023-04-20 2023-04-20
US18/612,750 US20240352470A1 (en) 2023-04-20 2024-03-21 Composition including probiotics for telomerase production
PCT/US2024/025516 WO2024220879A1 (en) 2023-04-20 2024-04-19 Composition including probiotics for telomerase production

Publications (1)

Publication Number Publication Date
EP4698283A1 true EP4698283A1 (de) 2026-02-25

Family

ID=91082002

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24726093.8A Pending EP4698283A1 (de) 2023-04-20 2024-04-19 Probiotika enthaltende zusammensetzung zur telomeraseherstellung

Country Status (5)

Country Link
EP (1) EP4698283A1 (de)
KR (1) KR20250167008A (de)
CN (1) CN121127255A (de)
AU (1) AU2024258084A1 (de)
WO (1) WO2024220879A1 (de)

Also Published As

Publication number Publication date
WO2024220879A1 (en) 2024-10-24
AU2024258084A1 (en) 2025-11-06
KR20250167008A (ko) 2025-11-28
CN121127255A (zh) 2025-12-12

Similar Documents

Publication Publication Date Title
ES2600963T3 (es) Células/Cepas Lactobacillus secadas por pulverización y su uso contra Helicobacter pylori
US9868957B2 (en) Topical composition comprising transformed bacteria expressing a compound of interest
JP2022084579A (ja) 粘膜付着性微生物
Van De Guchte et al. Stress responses in lactic acid bacteria
CN101679938B (zh) 益生双歧杆菌菌株
Fooladi et al. Genetically engineered bacteria: a new frontier in targeted drug delivery
ES2545209T3 (es) Método de obtención de una nueva cepa de Bifidobacterium bifidum con actividad frente a la infección por Helicobacter pylori
EA024087B1 (ru) Способ получения ферментированного молочного продукта при синергетической ферментации lactobacillus rhamnosus и lactobacillus paracasei subsp. paracasei
AU2021349560A1 (en) Muscle atrophy prevention agent
CN111304140A (zh) 产(r)-3-羟基丁酸的重组肠道菌及其构建方法
Anjum et al. The effect of thermal processing on probiotics stability
US20240352470A1 (en) Composition including probiotics for telomerase production
CN102329766A (zh) 可用于预防或治疗人溃疡性结肠炎的重组食品级乳酸菌、其制备方法与应用
EP4698283A1 (de) Probiotika enthaltende zusammensetzung zur telomeraseherstellung
ES2987983T3 (es) Pellets enzimáticos congelados
JP2026513668A (ja) テロメラーゼの産生のためのプロバイオティクスを含む組成物
KR20200145941A (ko) 락토바실러스 카제이 hy2782를 유효성분으로 함유하는 미세먼지에 의한 밀착연접단백질 관련 질환의 예방 또는 개선용 식품조성물
CN102265924B (zh) 高抗氧化及降血压活性乳酸菌发酵乳制品的生产方法
EP4417684A1 (de) Bakterium, das zur expression eines heterologen tat-proteins modifiziert ist
JP4473570B2 (ja) 生体内での微生物の生残性を向上させる方法及び生残性が向上した微生物
CN103562381A (zh) 缺失d-乳酸产生并且具有改进的贮藏期限的约氏乳杆菌菌株cncm i-1225的衍生物
de Jesus et al. Recombinant probiotics and microbiota modulation as a good therapy for diseases related to the GIT
KR101969420B1 (ko) 락토바실러스 카제이 hy2782를 유효성분으로 함유하는 미세먼지와 자외선으로 인한 산화적 스트레스 및 피부 보습을 개선하기 위한 조성물
Dey et al. Probiotic lactobacillus strains for enhanced health benefits (genetic engineering and microencapsulation)
CN111575309A (zh) 一种表达il-21的基因工程乳酸菌的构建方法及其在肿瘤免疫治疗中的应用

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR